Follow us on

Kiran Mazumdar support for pharma

Last Updated: Sun, Nov 18, 2012 19:20 hrs

Kiran Mazumdar-Shaw, CMD, Biocon Ltd, has said that both developed countries and emerging markets were now moving towards generic drugs. She added, with India emerging as biggest and low-cost generic producer, it provides a huge opportunity for India to gain from the growing generic drugs market. She has also demanded that the cost of capital needs to be subsidised, since pharmaceutical was a capital intensive business. Generic drugs is expected to be 40 per cent (value terms) of the global pharmaceutical market by 2015.

blog comments powered by Disqus
most popular on facebook
talking point on sify finance